Busulfex and stomatitis 
Busulfex and stomatitis Patient Reports February 13, 2012
Busulfex Side Effects Report #5878638-4
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Aug 28, 2008. Female patient, child 9 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, bone marrow transplant rejection, cystitis haemorrhagic, diarrhoea, hypokalaemia, malignant neoplasm progression, nausea
, stomatitis. Busulfex dosage: 11.1 ML, INTRAVENOUS; 14.8 ML, DAILY DOSE; INTRAVENOUS; 3.7 ML, DAILY DOSE, INTRAVENOUS. During the same period patient was treated with CYTARABINE, MELPHALAN, ETOPOSIDE, VALPROATE, METHOTREXATE, TACROLIMUS. Patient died.Busulfex Side Effects Report #5888696-9
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on July 07, 2008. Male patient, child 7 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: diarrhoea, interstitial lung disease, stomatitis, venoocclusive liver disease. Busulfex dosage: 75 MG 100 MG, DAILY DOSE 25 MG, DAILY DOSE; INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, VALPROATE, FILGRASTIM, TACROLIMUS. Patient died.
Busulfex Side Effects Report #5819493-8
Busulfex side effect was reported by a Health Professional from JAPAN on July 08, 2008. Male patient, 69 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, diarrhoea, graft versus host disease, jaundice cholestatic, malaise, nausea
, stomatitis. Busulfex dosage: 30 ML INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHSOPHATE, VALPROATE, MELPHALAN, FILGRASTIM, TACTROLIMUS. Patient was hospitalized. Patient recovered.Busulfex Side Effects Report #5874037-X
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Aug 19, 2008. Male patient, 66 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute graft versus host disease, acute myeloid leukaemia recurrent, blood bilirubin increased, cystitis, cytomegalovirus enterocolitis, interstitial lung disease, staphylococcal sepsis, stomatitis. Busulfex dosage: 25.5 ML, INTRAVENOUS, 34 ML, DAILY DOSE; INTRAVENOUS; 8.5 ML DAILY DOSE, INTRAVENOUS. During the same period patient was treated with CYTARABINE, FLUDARABINE PHOSPHATE, MELPHALAN, VALPROATE, FILGRASTIM, TACROLIMUS. Patient died.
Busulfex Side Effects Report #5878608-6
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Aug 25, 2008. Male patient, 65 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: convulsion, diarrhoea, encephalitis viral, pneumonia
, stem cell transplant, stomatitis. Busulfex dosage: 36.68 ML, DAILY DOSE INTRAVENOUS. During the same period patient was treated with MELPHALAN, TACROLIMUS. Patient died.Busulfex Side Effects Report #5886951-X
Busulfex side effect was reported by a Health Professional from JAPAN on Sept 02, 2008. Male patient, 65 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, bone marrow transplant rejection, graft versus host disease, malignant neoplasm progression, stomatitis. Busulfex dosage: 32 ML, INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, VALPROATE, FILGRASTIM, METHOTREXATE, TACROLIMUS. Patient was hospitalized. Patient recovered.
Busulfex Side Effects Report #5769154-9
Busulfex side effect was reported by a Physician from JAPAN on May 29, 2008. Female patient, 62 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, bone marrow transplant
, cytomegalovirus infection , enterocolitis viral, graft versus host disease, pneumonia , stomatitis. Busulfex dosage: 28 ML, INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, VALPROATE, LENOGRASTIM, METHOTREXATE, CYCLOSPORINE. Patient was hospitalized. Patient recovered.Busulfex Side Effects Report #5819491-4
Busulfex side effect was reported by a Health Professional from JAPAN on July 08, 2008. Male patient, 62 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, diarrhoea, enterococcal sepsis, malaise, nausea
, stomatitis, treatment failure. Busulfex dosage: 30 ML, INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, VALPROATE, MELPHALAN, FILGRASTIM, TACROLIMUS, MYCOPHENOLATE MOFETIL. Patient recovered.Busulfex Side Effects Report #5877275-5
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Aug 27, 2008. Male patient, 62 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, diarrhoea, enterococcal sepsis, leukaemia recurrent, malaise, nausea
, stomatitis. Busulfex dosage: 30 ML, UNK, INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, VALPROATE, MELPHALAN, FILGRASTIM, TACROLIMUS, MYCOPHENOLATE MOFETIL. Patient died on 05/15/2007.Busulfex Side Effects Report #5812208-9
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on July 01, 2008. Male patient, 60 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, bone marrow transplant rejection, catheter related infection, cytomegalovirus viraemia, diarrhoea, enterocolitis bacterial, nausea
, stomatitis. Busulfex dosage: 31.48 ML, DAILY DOSE INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, PHENYTOIN, FILGRASTIM, METHOTREXATE, TACROLIMUS. Patient was hospitalized. Patient recovered.Busulfex Side Effects Report #5839357-3
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on July 30, 2008. Male patient, 60 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia recurrent, diarrhoea, malaise, stomatitis. Busulfex dosage: 192 ML, INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, VALPROATE, FILGRASTIM, METHOTREXATE, TACROLIMUS. Patient recovered.
Busulfex Side Effects Report #5822822-2
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on July 14, 2008. Female patient, child 6 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, febrile neutropenia, malaise, stomatitis. Busulfex dosage: 72 MG INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, MELPHALAN, PHENYTOIN, FILGRASTIM, METHOTREXATE, CYCLOSPORINE. Patient recovered.
Busulfex Side Effects Report #5798835-6
Busulfex side effect was reported by a Health Professional from JAPAN on June 16, 2008. Male patient, 58 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia recurrent, anorexia, enterocolitis, febrile neutropenia, graft versus host disease, malaise, nausea
, stomatitis. Busulfex dosage: 460 MG INTRAVENOUS. During the same period patient was treated with PHENYTOIN, NEUPOGEN, MITOXANTRONE HYDROCHLORIDE, METHOTREXATE, CYCLOSPORINE, MITOXANTRONE HYDROCHLORIDE. Patient died.Busulfex Side Effects Report #5834906-3
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Aug 22, 2007. Male patient, 58 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute graft versus host disease, anorexia, diarrhoea, gamma-glutamyltransferase increased, staphylococcal sepsis, stomatitis. Busulfex dosage: 27 ML, INTRAVENOUS ; 36 ML, DAILY DOSE; INTRAVENOUS ; 9 ML, DAILY DOSE; INTRAVENOUS. During the same period patient was treated with FILGRASTIM, VALPROATE, FLUDARABINE PHOSPHATE, METHOTREXATE, CYCLOSPORINE, FOSCARNET. Patient was hospitalized. Patient recovered.
Busulfex Side Effects Report #6060141-2
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Jan 15, 2009. Male patient, 58 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia recurrent, anorexia, enterocolitis viral, febrile neutropenia, graft versus host disease, malaise, nausea
, stomatitis. Busulfex dosage: 460 MG, INTRAVENOUS. During the same period patient was treated with METHOTREXATE, CYCLOSPORINE, MITOXANTRONE HYDROCHLORIDE, FLUDARABINE PHOSPHATE, PHENYTOIN, FILGRASTIM. Patient died on 11/18/2007.Busulfex Side Effects Report #5893736-7
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Sept 04, 2008. Female patient, 57 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, bacterial sepsis, malaise, pseudomonal sepsis, septic shock, stomatitis. Busulfex dosage: 12.8 MG/KG, INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOSPORINE, FILGRASTIM. Patient died.
Busulfex Side Effects Report #5912041-3
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Sept 25, 2008. Male patient, 57 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: enterococcal sepsis, febrile neutropenia, haemorrhoids, malaise, malignant neoplasm progression, pruritus, rash
, stomatitis. Busulfex dosage: 14.8 ML, DAILY DOSE INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, VALPROATE, FILGRASTIM, LENOGRASTIM, METHOTREXATE, CYCLOSPORINE. Patient recovered.Busulfex Side Effects Report #5729824-5
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Apr 21, 2008. Male patient, 54 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute graft versus host disease, diarrhoea, localised infection, malaise, staphylococcal infection
, stomatitis. Busulfex dosage: unknown. During the same period patient was treated with FLUDARABINE PHOSPHATE, PHENYTOIN, LENOGRASTIM, TACROLIMUS HYDRATE. Patient was hospitalized. Patient recovered.Busulfex Side Effects Report #5819439-2
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on July 08, 2008. Female patient, 54 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: bone marrow transplant
, cytomegalovirus enterocolitis, graft versus host disease, stomatitis. Busulfex dosage: 156 ML, INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, VALPROATE, FILGRASTIM, CYCLOSPORINE. Patient was hospitalized. Patient recovered.Busulfex Side Effects Report #5809452-3
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on June 23, 2008. Male patient, 53 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, malaise, malignant neoplasm progression, nausea
, pneumonia , staphylococcal sepsis, stem cell transplant, stomatitis. Busulfex dosage: 7.5 ML, INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, VALPROATE, NEUPOGEN, METHOTREXATE, CYCLOSPORINE. Patient died on 08/15/2007.Busulfex Side Effects Report #5811572-4
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on July 01, 2008. Male patient, 53 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, malaise, peritonsillitis, stomatitis. Busulfex dosage: 32 ML, DAILY DOSE. During the same period patient was treated with FLUDARABINE PHOSPHATE, VALPROATE, FILGRASTIM, METHOTREXATE, CYCLOSPORINE. Patient recovered.
Busulfex Side Effects Report #5859370-X
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Aug 13, 2008. Female patient, 53 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: diarrhoea, pseudomonal sepsis, stomatitis. Busulfex dosage: 30 ML, DAILY DOSE INTRAVENOUS. During the same period patient was treated with PHENYTOIN, METHOTREXATE, TACROLIMUS, CYCLOPHOSPHAMIDE, FILGRASTIM. Patient was hospitalized. Patient recovered.
Busulfex Side Effects Report #5819579-8
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on July 07, 2008. Male patient, 51 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: cytomegalovirus chorioretinitis, graft versus host disease, interstitial lung disease, stem cell transplant, stomatitis, viral haemorrhagic cystitis. Busulfex dosage: 25.6 ML, INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, VALPROATE, LENOGRASTIM, METHOTREXATE, CYCLOSPORINE. Patient was hospitalized. Patient died.
Busulfex Side Effects Report #5819606-8
Busulfex side effect was reported by a Health Professional from JAPAN on July 08, 2008. Male patient, 51 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, cystitis haemorrhagic, diarrhoea, malaise, malignant neoplasm progression, nausea
, stem cell transplant, stomatitis. Busulfex dosage: 24 ML, DAILY DOSE INTRAVENOUS; 32 ML, DAILY DOSE; INTRAVENOUS; 8 ML, DAILY DOSE; INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, VALPROATE, FILGRASTIM, METHOTREXATE, CYCLOSPORINE. Patient was hospitalized. Patient died on 08/26/2007.Busulfex Side Effects Report #5893732-X
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Sept 05, 2008. Female patient, 51 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute graft versus host disease, adult t-cell lymphoma/leukaemia recurrent, anorexia, bone marrow transplant
, cytomegalovirus enterocolitis, malaise, stomatitis, vomiting. Busulfex dosage: 24 ML, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, VALPROATE, FILGRASTIM, METHOTREXATE, TACROLIMUS. Patient recovered.Busulfex Side Effects Report #5729827-0
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Apr 21, 2008. Male patient, 50 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: abdominal pain
, acute graft versus host disease, cytomegalovirus viraemia, diarrhoea, febrile neutropenia, malaise, rash , stomatitis. Busulfex dosage: 24 ML, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, NEUPOGEN, METHOTREXATE, TACROLIMUS. Patient was hospitalized. Patient recovered.Busulfex Side Effects Report #5818265-8
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on July 07, 2008. Male patient, 50 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, bacterial sepsis, diarrhoea, enterococcal sepsis, nausea
, stomatitis. Busulfex dosage: 153 MG, DAILY DOSE, INTRAVENOUS ; 204 MG, DAILY DOSE; INTRAVENOUS; 51 MG, DAILY DOSE; INTRAVENO. During the same period patient was treated with CYCLOPHOSPHAMIDE, VALPROATE, METHOTREXATE, TACROLIMUS. Patient recovered.Busulfex Side Effects Report #5894819-8
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Sept 11, 2008. Male patient, 50 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: bacterial sepsis, bone marrow transplant rejection, diarrhoea, enterococcal sepsis, nausea
, stomatitis. Busulfex dosage: 153 MG, DAILY DOSE INTRAVENOUS; 204 MG, DAILY DOSE; INTRAVENOUS; 51 MG, DAILY DOSE; INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, VALPROATE, METHOTREXATE, TACROLIMUS. Patient recovered.Busulfex Side Effects Report #5819591-9
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on July 07, 2008. Male patient, 49 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, graft versus host disease, jaundice
, malaise, nausea , stomatitis. Busulfex dosage: 24 ML; 32 ML, DAILY DOSE; INTRAVENOUS; 8 ML, DAILY DOSE; INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, VALPROATE, FILGRASTIM, CYCLOSPORINE. Patient recovered.Busulfex Side Effects Report #5767623-9
Busulfex side effect was reported by a Consumer or non-health professional from KOREA, REPUBLIC OF on May 27, 2008. Male patient, 44 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: chronic graft versus host disease, cytomegalovirus infection
, hepatic enzyme increased, stomatitis, thrombotic microangiopathy. Busulfex dosage: unknown. During the same period patient was treated with FLUDARABINE PHOSPHATE, METHOTREXATE, CYCLOSPORINE. Patient was hospitalized. Patient recovered.Busulfex Side Effects Report #5979835-X
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Nov 12, 2008. Female patient, 44 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, blood urea increased, jaundice
, malaise, sepsis , stomatitis. Busulfex dosage: 30 MG, QID, INTRAVENOUS. During the same period patient was treated with DEPAKENE, CYCLOPHOSPHAMIDE, METHOTREXATE, TACROLIMUS, METHYLPREDNISOLONE, CELLCEPT USA. Patient died on 07/16/2007.Busulfex Side Effects Report #6026259-5
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Dec 18, 2008. Female patient, 44 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: blood urea increased, jaundice
, sepsis , stomatitis. Busulfex dosage: 30 MG, QID. During the same period patient was treated with DEPAKENE, CYCLOPHOSPHAMIDE, METHOTREXATE, TACROLIMUS, METHYLPREDNISOLONE, CELLCEPT USA. Patient died on 07/16/2007.Busulfex Side Effects Report #6016154-X
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Dec 09, 2008. Female patient, 43 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute graft versus host disease, anorexia, chronic graft versus host disease, diarrhoea, hyponatraemia, malaise, pharyngitis, stomatitis. Busulfex dosage: 22 ML INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, VALPROATE, FILGRASTIM, METHOTREXATE. Patient died on 08/31/2008.
Busulfex Side Effects Report #5819426-4
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on July 08, 2008. Male patient, 42 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia recurrent, nausea
, sepsis , stomatitis. Busulfex dosage: 150 ML, INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, VALPROATE, TACROLIMUS. Patient was hospitalized. Patient recovered.Busulfex Side Effects Report #5831998-2
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on July 22, 2008. Male patient, 42 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, diarrhoea, malaise, malignant neoplasm progression, phlebitis, stomatitis. Busulfex dosage: 24 ML, DAILY DOSE; 32 ML, DAILY DOSE. During the same period patient was treated with CYCLOPHOSPHAMIDE, VALPROATE, FILGRASTIM, METHOTREXATE, CYCLOSPORINE. Patient recovered.
Busulfex Side Effects Report #6016160-5
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Dec 09, 2008. Male patient, 42 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: nausea
, sepsis , stomatitis. Busulfex dosage: 150 ML INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, VALPROATE, TACROLIMUS. Patient was hospitalized. Patient recovered.Busulfex Side Effects Report #5921366-7
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Oct 01, 2008. Female patient, 41 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, cytomegalovirus antibody positive, malaise, nausea
, pneumonia cytomegaloviral, respiratory failure, stomatitis. Busulfex dosage: 3.2 MG, INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYTARABINE, CYCLOSPORINE, CELLCEPT USA, NEUTROGIN. Patient died.Busulfex Side Effects Report #5900854-3
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Sept 16, 2008. Male patient, child 4 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: blood potassium decreased, bone marrow transplant rejection, dysphagia, haemodialysis, hepatic cirrhosis, malaise, mucosal erosion, stomatitis, venoocclusive liver disease. Busulfex dosage: 8.1 ML; 10.8 ML, DAILY DOSE; INTRAVENOUS; 2.7 ML, DAILY DOSE; INTRAVENOUS. During the same period patient was treated with MELPHALAN, PHENYTOIN, FILGASTRIM. Patient was hospitalized. Patient recovered.
Busulfex Side Effects Report #5819595-6
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on July 07, 2008. Female patient, 36 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, bacterial sepsis, diarrhoea, enterobacter sepsis, malaise, nausea
, pneumonia viral, stomatitis. Busulfex dosage: 165 ML, DAILY DOSE; 220 ML, DAILY DOSE; INTRAVENOUS; 55 ML, DAILY DOSE; INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, VALPROATE, MELPHALAN, FILGRASTIM, TACROLIMUS. Patient died.Busulfex Side Effects Report #5877265-2
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Aug 25, 2008. Male patient, 35 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia recurrent, enterococcal sepsis, hyperkalaemia, liver disorder, renal failure, stenotrophomonas sepsis, stomatitis, ventricular fibrillation. Busulfex dosage: 34 ML, DAILY DOSE INTRAVENOUS. During the same period patient was treated with CYCLOSPORINE, FLUDARABINE PHOSPHATE, VALPROATE, FILGRASTIM. Patient died on 06/15/2007.
Busulfex Side Effects Report #5979845-2
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Nov 13, 2008. Male patient, 35 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: enterococcal sepsis, hyperkalaemia, liver disorder, renal failure, stenotrophomonas sepsis, stomatitis, ventricular fibrillation. Busulfex dosage: 34 ML, DAILY DOSE, INTRAVENOUS. During the same period patient was treated with CYCLOSPORINE, FLUDARABINE PHOSPHATE, VALPROATE, FILGRASTIM. Patient died.
Busulfex Side Effects Report #6025478-1
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Dec 17, 2008. Male patient, 35 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: enterococcal sepsis, liver disorder, renal failure, stenotrophomonas sepsis, stomatitis, ventricular fibrillation. Busulfex dosage: 34 ML, DAILY DOSE INTRAVENOUS. During the same period patient was treated with CYCLOSPORINE, FLUDARABINE PHOSPHATE, VALPROATE, FILGRASTIM. Patient died on 06/16/2007.
Busulfex Side Effects Report #5906671-2
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Sept 19, 2008. Female patient, 31 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute lymphocytic leukaemia recurrent, bone marrow transplant
, diarrhoea, nausea , stomatitis. Busulfex dosage: unknown. During the same period patient was treated with FLUDARABINE PHOSPHATE, VALPROATE, LENOGRASTIM, METHOTREXATE, TACROLIMUS. Patient recovered.Busulfex Side Effects Report #5818263-4
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on July 07, 2008. Female patient, child 3 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, diarrhoea, febrile neutropenia, graft versus host disease, stomatitis. Busulfex dosage: 7.8 ML, DAILY DOSE; 10.4 ML, DAILY DOSE; 2.6 ML, DAILY DOSE. During the same period patient was treated with ETOPOSIDE, CYCLOPHOSPHAMIDE, VALPROATE, LENOGRASTIM, METHOTREXATE, TACROLIMUS. Patient recovered.
Busulfex Side Effects Report #5886251-8
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Aug 29, 2008. Male patient, child 3 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute graft versus host disease, anorexia, diarrhoea, malaise, neuroblastoma recurrent, stomatitis. Busulfex dosage: 10.4 ML, INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, VALPROATE, LENOGRASTIME, METHOTREXATE, TACROLIMUS. Patient recovered.
Busulfex Side Effects Report #5886254-3
Busulfex side effect was reported by a Health Professional from JAPAN on Sept 01, 2008. Female patient, child 3 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute graft versus host disease, acute lymphocytic leukaemia recurrent, anorexia, diarrhoea, febrile neutropenia, hepatic function abnormal, stomatitis. Busulfex dosage: 7.8 ML, DAILY DOSE INTRAVENOUS; 10.4 ML, DAILY DOSE; INTRAVENOUS; 2.6 ML, DAILY DOSE; INTRAVENOUS. During the same period patient was treated with ETOPOSIDE, CYCLOPHOSPHAMIDE, VALPROATE, LENOGRASTIM, METHOTREXATE, TRACOLIMUS. Patient recovered.
Busulfex Side Effects Report #5698188-8
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Mar 21, 2008. Female patient, 29 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: bone marrow transplant
, bronchopulmonary aspergillosis, serratia sepsis, stomatitis, venoocclusive liver disease. Busulfex dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, VALPROATE, LENOGRATIM, METHOTREXATE, CYCLOSPORINE. Patient recovered.Busulfex Side Effects Report #5849781-0
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Aug 08, 2008. Female patient, 29 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute graft versus host disease, acute myeloid leukaemia recurrent, anorexia, diarrhoea, malaise, pharyngitis, stomatitis. Busulfex dosage: 11 ML, INTRAVENOUS, 22 ML, DAILY DOSE; INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, PHENYTOIN, FILGRASTIM, METHOTREXATE, TACROLIMUS. Patient recovered.
Busulfex Side Effects Report #5888684-2
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on May 29, 2008. Male patient, 28 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute graft versus host disease, diarrhoea, febrile neutropenia, stomatitis, thrombotic microangiopathy. Busulfex dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, PHENYTOIN, NARTOGRASTIM. Patient was hospitalized. Patient recovered.
Busulfex Side Effects Report #5698126-8
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Mar 21, 2008. Male patient, 25 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: bone marrow transplant
, bone marrow transplant rejection, perianal abscess, pneumonia staphylococcal, staphylococcal pharyngitis, stomatitis, surgical procedure repeated. Busulfex dosage: unknown. Patient died.Busulfex Side Effects Report #6060139-4
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Jan 16, 2009. Female patient, 23 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute graft versus host disease, anorexia, aplasia pure red cell, stomatitis. Busulfex dosage: 0.8 MG/KG, QID INTRAVENOUS. During the same period patient was treated with CYTARABINE, FLUDARABINE PHOSPHATE, FILGRASTIM, SANDIMMUNE. Patient was hospitalized. Patient recovered.
Busulfex Side Effects Report #5698136-0
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Mar 21, 2008. Female patient, 21 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: candida sepsis, cardiogenic shock, pneumonia
, staphylococcal sepsis, stomatitis. Busulfex dosage: unknown. Patient died.Busulfex Side Effects Report #5800895-0
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on June 20, 2008. Female patient, child 2 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, enterococcal sepsis, malaise, nausea
, stomatitis. Busulfex dosage: 10 ML, DAILY DOSE. During the same period patient was treated with MELPHALAN, CLONAZEPAM, NEUPOGEN, METHOTREXATE, CYCLOSPORINE. Patient recovered.Busulfex Side Effects Report #5811613-4
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on July 01, 2008. Female patient, child 2 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia recurrent, conjunctivitis, diarrhoea, idiopathic pneumonia syndrome, keratitis, stomatitis. Busulfex dosage: 8.4 ML, DAILY DOSE. During the same period patient was treated with FLUDARABINE PHOSPHATE, MELPHALAN, PHENYTOIN, MIRIMOSTIM, METHOTREXATE, TACROLIMUS. Patient was hospitalized. Patient died.
Busulfex Side Effects Report #5869635-3
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Aug 18, 2008. Female patient, child 2 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, enterococcal sepsis, malaise, nausea
, platelet count decreased, stomatitis. Busulfex dosage: 10 ML, DAILY DOSE INTRAVENOUS. During the same period patient was treated with GEMTUZUMAB, MELPHALAN, CLONAZEPAM, FILGRASTIM, METHOTREXATE, CYCLOSPORINE. Patient recovered.Busulfex Side Effects Report #5877277-9
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Aug 25, 2008. Female patient, child 2 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute graft versus host disease, febrile neutropenia, stomatitis, venoocclusive liver disease. Busulfex dosage: 7.5 ML, UNK, INTRAVENOUS, 10 ML, DAILY DOSE; INTRAVEOUS, 2.5 ML, DAILY DOSE; INTRAVENOUS. During the same period patient was treated with MELPHALAN, VALPROATE, FILGRATIM, METHOTREXATE, CYCLOSPORINE, TACROLIMUS. Patient was hospitalized. Patient recovered.
Busulfex Side Effects Report #5933574-X
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Oct 14, 2008. Female patient, child 2 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, enterococcal sepsis, hyponatraemia, nausea
, platelet count decreased, stomatitis. Busulfex dosage: 10 ML, DAILY DOSE, INTRAVENOUS. During the same period patient was treated with GEMTUZUMAB OZOGAMICIN, MELPHALAN, CLONAZEPAM, FILGRASTIM, METHOTREXATE, CYCLOSPORINE. Patient recovered.Busulfex Side Effects Report #5811550-5
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on July 01, 2008. Female patient, 18 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, diarrhoea, malaise, sepsis
, stem cell transplant, stomatitis, thrombotic microangiopathy, venoocclusive liver disease. Busulfex dosage: 13 ML, DAILY DOSE; 26 ML, DAILY DOSE. During the same period patient was treated with VALPROATE, MELPHALAN, FILGRASTIM, CYCLOSPORINE. Patient recovered.Busulfex Side Effects Report #5782932-5
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on June 11, 2008. Male patient, 17 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, bone marrow transplant
, diarrhoea, malaise, nausea , sepsis , stomatitis. Busulfex dosage: 40 ML, INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, VALPROATE, LENOGRASTIM, METHOTREXATE, TACROLIMUS. Patient recovered.Busulfex Side Effects Report #6103239-2
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Feb 16, 2009. Female patient, 17 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute graft versus host disease, bone marrow transplant rejection, hepatic function abnormal, stomatitis. Busulfex dosage: 25 MG, QID, INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, PHENYTOIN, LYMPHOGLOBULINE, FILGRASTIM, CYCLOSPORINE. Patient was hospitalized. Patient recovered.
Busulfex Side Effects Report #5822815-5
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on July 14, 2008. Female patient, 13 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, bone marrow transplant
, febrile neutropenia, malaise, stomatitis, transplant rejection. Busulfex dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, ANTILYMPHOCYTE IMMUNOGLOBULIN, PHENYTOIN, FILGRASTIM, METHOTREXATE, CYCLOSPORINE. Patient recovered.Busulfex Side Effects Report #5819420-3
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on July 08, 2008. Female patient, child 12 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, cellulitis
, malaise, nail infection, nausea , pseudomonas infection, staphylococcal sepsis, stomatitis. Busulfex dosage: 14.1 ML, INTRAVENOUS; 18.8 ML, DAILY DOSE; INTRAVENOUS; 4.7 ML, DAILY DOSE; INTRAVENOUS. During the same period patient was treated with ETOPOSIDE, FLUDARABINE PHOSPHATE, VALPROATE, LENOGRASTIM, METHOTREXATE, TACROLIMUS. Patient recovered.Busulfex Side Effects Report #5979846-4
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Nov 14, 2008. Male patient, child 11 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, bone marrow transplant rejection, diarrhoea, hypokalaemia, nausea
, polyomavirus-associated nephropathy, stomatitis, thrombocytopenia, venoocclusive liver disease. Busulfex dosage: 5.2 ML, TID, INTRAVENOUS; 5.2 ML, QID, INTRAVENOUS; 5.2 ML, QD, INTRAVENOUS. During the same period patient was treated with DEPAKENE, MELPHALAN, NEUTROGIN, METHOTREXATE, TACROLIMUS. Patient was hospitalized. Patient recovered.Busulfex Side Effects Report #5698114-1
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Mar 21, 2008. Male patient, child 10 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: malaise, multi-organ failure, stomatitis, venoocclusive liver disease. Busulfex dosage: 8 ML, INTRAVENOUS. Patient died.
Busulfex Side Effects Report #5803069-2
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on June 23, 2008. Female patient was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute lymphocytic leukaemia recurrent, anorexia, convulsion, diarrhoea, graft versus host disease, nausea
, respiratory disorder, stomatitis, venoocclusive liver disease. Busulfex dosage: unknown. During the same period patient was treated with ETOPOSIDE, CYCLOPHOSPHAMIDE, CLONAZEPAM, NEUPOGEN, METHOTREXATE, TACROLIMUS. Patient recovered.Busulfex Side Effects Report #5803070-9
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on June 23, 2008. Female patient was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute lymphocytic leukaemia recurrent, anorexia, diarrhoea, malaise, nausea
, stomatitis. Busulfex dosage: 3.9 ML, INTRAVENOUS; 5.2 ML, DAILY DOSE; INTRAVENOUS; 1.3 ML, DAILY DOSE; INTRAVENOUS. During the same period patient was treated with ETOPOSIDE, CYCLOPHOSPHAMIDE, CLONZEPAM, LENOGRASTIM, METHOTREXATE, CYCLOSPORINE. Patient recovered.Busulfex Side Effects Report #5989260-3
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Nov 25, 2008. Female patient was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute lymphocytic leukaemia recurrent, bone marrow transplant
, nausea , neutropenia, pyrexia, respiratory disorder, sepsis , stomatitis, venoocclusive liver disease. Busulfex dosage: 2.4 ML, INTRAVENOUS. During the same period patient was treated with CLONAZEPAM, ZONISAMIDE, ETOPOSIDE, CYCLOPHOSPHAMIDE, FILGRASTIM, METHOTREXATE, TACROLIMUS. Patient recovered.Busulfex Side Effects Report #5990193-7
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Nov 25, 2008. Female patient was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute lymphocytic leukaemia recurrent, nausea
, neutropenia, pyrexia, respiratory disorder, sepsis , stomatitis, venoocclusive liver disease. Busulfex dosage: 2.4 ML. During the same period patient was treated with CLONAZEPAM, ZONISAMIDE, ETOPOSIDE, CYCLOPHOSPHAMIDE, FILGRASTIM, METHOTREXATE, TACROLIMUS. Patient recovered.Busulfex Side Effects Report #4631468-3
Busulfex side effect was reported by a Consumer or non-health professional from on Apr 01, 2005. Male patient, 34 years of age, was treated with Busulfex. After drug was administered, patient experienced the following side effects: complications of bone marrow transplant, hepatomegaly, stomatitis, venoocclusive liver disease. Busulfex dosage: 220 MG. Patient was hospitalized. Patient recovered.
Busulfex Side Effects Report #4631468-3
Busulfex side effect was reported by a Consumer or non-health professional from KOREA, DEMOCRATIC PEOPLE'S REPUBLIC OF on Apr 01, 2005. Male patient, 34 years of age, was treated with Busulfex. After drug was administered, patient experienced the following side effects: complications of bone marrow transplant, hepatomegaly, stomatitis, venoocclusive liver disease. Busulfex dosage: 220 MG. Patient was hospitalized. Patient recovered.